Kiora Pharmaceuticals

KPRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.857 M

$2.68 -2.90%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$10.8K

Loss-making

Shares outstanding

4,424,387

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#421EnlivexENLV$12.1M
#422BioLineRxBLRX$12.0M
#423Kiora PharmaceuticalsKPRX$11.9M
#424Phio PharmaceuticalsPHIO$11.7M
#425Adial PharmaceuticalsADIL$11.6M

What if Kiora Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$6,842,542

Per share 2,553,187× higher

Bitcoin $1.72T

$388,710.06

Per share 145,041× higher

Nvidia $5.48T

$1,238,558

Per share 462,148× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Kiora Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.